5-HT3 Receptor Antagonists
- 1 October 1991
- journal article
- review article
- Published by Springer Nature in Drugs
- Vol. 42 (4) , 551-568
- https://doi.org/10.2165/00003495-199142040-00002
Abstract
No abstract availableKeywords
This publication has 95 references indexed in Scilit:
- Double-blind crossover trial of single vs. divided dose of metoclopramide in a combined regimen for treatment of cisplatin-induced emesisEuropean Journal of Cancer and Clinical Oncology, 1991
- GranisetronDrugs, 1991
- OndansetronDrugs, 1991
- Comparison of the 5-Hydroxytryptamine3(Serotonin) Antagonist Ondansetron (Gr 38032F) with High-Dose Metoclopramide in the Control of Cisplatin-Induced EmesisNew England Journal of Medicine, 1990
- Efficacy of Ondansetron (Gr 38032F) and the Role of Serotonin in Cisplatin-Induced Nausea and VomitingNew England Journal of Medicine, 1990
- A comparison of ondansetron with metoclopramide in the prophylaxis of chemotherapy-induced nausea and vomiting: A randomized, double-blind studyEuropean Journal of Cancer and Clinical Oncology, 1990
- Correlation of anti-emetic efficacy and plasma levels of ondansetronEuropean Journal of Cancer and Clinical Oncology, 1990
- The effect of three dose levels of ICS 205–930 (a selective 5HT-3 antagonist) on cisplatin-induced nausea and vomitingEuropean Journal of Cancer and Clinical Oncology, 1989
- Substituted benzamides. 1. Potential nondopaminergic antagonists of chemotherapy-induced nausea and emesisJournal of Medicinal Chemistry, 1988
- Antiemetic Efficacy of High-Dose Metoclopramide: Randomized Trials with Placebo and Prochlorperazine in Patients with Chemotherapy-Induced Nausea and VomitingNew England Journal of Medicine, 1981